News
The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the ...
Researchers identified a direct connection between cancer-related inflammation and the loss of motivation characteristic of advanced cancer. In a mouse study, they describe a brain pathway that starts ...
The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the ...
A study identifies a brain pathway linking inflammation to dopamine loss and apathy in cancer. Researchers found that IL-6 ...
Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.
New research shows that apathy and fatigue in advanced cancer are driven not by physical decline, but by inflammation-sensing neurons that suppress motivation.
Science Featured on MSN12h
Key Protein Glycosylation Found to Drive Lung Cancer's Deadly Resistance to DrugsRecent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...
13d
MedPage Today on MSNStudy: Treat Adult-Onset Still's Disease With BiologicsOne of the worst complications of adult-onset Still's disease is macrophage activation syndrome (MAS), which can be fatal. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results